批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期 | 提交号 | 审批结论 | 申请内容分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
2023/11/22 |
SUPPL-13(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2022/03/16 |
SUPPL-10(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2022/03/16 |
SUPPL-9(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2015/01/12 |
SUPPL-6(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2014/09/04 |
SUPPL-5(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2011/10/19 |
SUPPL-4(补充) |
Approval |
Labeling |
UNKNOWN
|
|
|
2010/03/05 |
SUPPL-3(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2006/08/29 |
SUPPL-2(补充) |
Approval |
Manufacturing (CMC) |
N/A
|
|
|
2005/11/14 |
SUPPL-1(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2005/06/30 |
ORIG-1(原始申请) |
Approval |
Type 3 - New Dosage Form |
STANDARD
|
|
|
与本品相关的专利信息(来自FDA橙皮书Orange Book)
与本品治疗等效的药品
活性成分:METRONIDAZOLE 剂型/给药途径:GEL;TOPICAL 规格:1% 治疗等效代码:AB
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
021789 |
001 |
NDA |
METROGEL |
METRONIDAZOLE |
GEL;TOPICAL |
1% |
Prescription |
Yes |
Yes |
AB |
2005/06/30
|
GALDERMA LABS LP |
090903 |
001 |
ANDA |
METRONIDAZOLE |
METRONIDAZOLE |
GEL;TOPICAL |
1% |
Discontinued |
No |
No |
AB |
2011/07/22
|
CHARTWELL RX |
204651 |
001 |
ANDA |
METRONIDAZOLE |
METRONIDAZOLE |
GEL;TOPICAL |
1% |
Prescription |
No |
No |
AB |
2017/03/14
|
TARO |
212646 |
001 |
ANDA |
METRONIDAZOLE |
METRONIDAZOLE |
GEL;TOPICAL |
1% |
Prescription |
No |
No |
AB |
2021/09/03
|
ALEMBIC |
216692 |
001 |
ANDA |
METRONIDAZOLE |
METRONIDAZOLE |
GEL;TOPICAL |
1% |
Prescription |
No |
No |
AB |
2023/01/23
|
COSETTE |
218941 |
001 |
ANDA |
METRONIDAZOLE |
METRONIDAZOLE |
GEL;TOPICAL |
1% |
Prescription |
No |
No |
AB |
2024/10/15
|
AUROBINDO PHARMA LTD |